Cargando…

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy

Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling. However, the underlying regulatory mechanism remains to be elucidated. Here we identified a heart-enriched long non-coding (lnc)RNA, named Cardiac Hypertrophy Associated Epigeneti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihua, Zhang, Xiao-Jing, Ji, Yan-Xiao, Zhang, Peng, Deng, Ke-Qiong, Gong, Jun, Ren, Shuxun, Wang, Xinghua, Chen, Iris, Wang, He, Gao, Chen, Yokota, Tomohiro, Ang, Yen Sin, Li, Shen, Cass, Ashley, Vondriska, Thomas M., Li, Guangping, Deb, Arjun, Srivastava, Deepak, Yang, Huang-Tian, Xiao, Xinshu, Li, Hongliang, Wang, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053883/
https://www.ncbi.nlm.nih.gov/pubmed/27618650
http://dx.doi.org/10.1038/nm.4179
Descripción
Sumario:Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling. However, the underlying regulatory mechanism remains to be elucidated. Here we identified a heart-enriched long non-coding (lnc)RNA, named Cardiac Hypertrophy Associated Epigenetic Regulator (Chaer), necessary for the development of cardiac hypertrophy. Mechanistically, Chaer directly interacts with Polycomb Repressor Complex 2 (PRC2) catalytic subunit through a 66-mer motif, interferes with its targeting to genomic locus, and subsequently inhibits histone H3 lysine 27 methylation at hypertrophic genes. This interaction is transiently induced upon hormone or stress stimulation in an mTORC1 dependent manner, and is prerequisite for epigenetic reprogramming and induction of hypertrophic genes. Inhibition of Chaer in intact heart before, but not after, the onset of pressure overload significantly attenuates cardiac hypertrophy and dysfunction. Therefore, our study reveals that stress-induced pathological gene activation in heart requires a previously uncharacterized lncRNA-dependent epigenetic checkpoint.